Vericel Corporation
Insiders
Last 12 monthsSales planned on beside the trades reported on , and whether each names a .
Planned ·
$13.1M
35 notices · 292,205 sh
Reported ·
$13.1M
47 sales · 0 buys
40 of 47 reported sales carry the 10b5-1 box. Together they are 0.57% of the shares on issue.
under a no plan named▼ salesize is dollars
Form 144 notices, newest first
Nov 13SIEGAL JONATHAN, Principal Accounting Officer$108,780
Form 4, Nov 17: sold 1,885 at $57.71 Form 4 ↗
Nov 11Mara Joseph Anthony Jr, Chief Financial Officer$478
Nov 10MCLAUGHLIN KEVIN F, Director$408,730
Form 4, Nov 12: sold 7,000 at $58.96 Form 4 ↗
Nov 9ZERBE ROBERT L MD, Director$115,753
Form 4, Nov 12: sold 2,000 at $57.88 Form 4 ↗
Nov 9Mara Joseph Anthony Jr, Chief Financial Officer$1,456,544
Form 4, Nov 12: sold 25,008 at $58.26 Form 4 ↗
Nov 6Mara Joseph Anthony Jr, Chief Financial Officer$1,529,938
Nov 5Mara Joseph Anthony Jr, Chief Financial Officer$1,144,078
Form 4, Nov 9: sold 50,000 at $53.48The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 2, 2025. Form 4 ↗
Nov 5Flynn Sean C., Chief Legal Officer$778,859
Form 4, Nov 6: sold 15,000 at $51.92The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 2, 2025. Form 4 ↗
Nov 5ZERBE ROBERT L MD, Director$156,682
Nov 5SIEGAL JONATHAN, Principal Accounting Officer$79,350
Form 4, Nov 6: sold 1,500 at $52.90The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 10, 2025. Form 4 ↗
Nov 4ZERBE ROBERT L MD, Director$113,502
Form 4, Nov 6: sold 5,500 at $49.12The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 19, 2026. Form 4 ↗
Aug 12MCLAUGHLIN KEVIN F, Director$308,770
Form 4, Aug 14: sold 7,000 at $44.53The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 12, 2025. Form 4 ↗
Aug 3Halpin Michael, Chief Operating Officer$459,800
Form 4, Aug 5: sold 10,000 at $46.84The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 2, 2025. Form 4 ↗
Jul 30SIEGAL JONATHAN, Principal Accounting Officer$220,050
Form 4, Jul 31: sold 4,500 at $48.90The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 10, 2025. Form 4 ↗
Jun 26Flynn Sean C., Chief Legal Officer$684,659
Form 4, Jun 30: sold 15,000 at $45.64The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 2, 2025. Form 4 ↗
Jun 26Mara Joseph Anthony Jr, Chief Financial Officer$223,750
Form 4, Jun 30: sold 5,000 at $44.75The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 2, 2025. Form 4 ↗
Jun 26SIEGAL JONATHAN, Principal Accounting Officer$122,667
Form 4, Jun 30: sold 2,732 at $44.90The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 10, 2025. Form 4 ↗
Jun 26Hopper Jonathan Mark, Chief Medical Officer$450,000
Form 4, Jun 30: sold 10,000 at $45.00The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 30, 2025. Form 4 ↗
Jun 18Flynn Sean C., Chief Legal Officer$603,148
Form 4, Jun 22: sold 15,000 at $40.21The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 2, 2025. Form 4 ↗
Jun 18Halpin Michael, Chief Operating Officer$402,401
Form 4, Jun 22: sold 10,000 at $40.24The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 2, 2025. Form 4 ↗
Jun 2Hopper Jonathan Mark, Chief Medical Officer$153,125
Form 4, Jun 4: sold 4,375 at $35.00 Form 4 ↗
May 13MCLAUGHLIN KEVIN F, Director$227,990
Form 4, May 15: sold 7,000 at $32.83 Form 4 ↗
May 11Wotton Paul K, Director$327,425
Form 4, May 13: sold 10,000 at $32.74 Form 4 ↗
May 7SIEGAL JONATHAN, Principal Accounting Officer$57,591
May 7Mara Joseph Anthony Jr, Chief Financial Officer$202,500
Form 4, May 8: sold 5,000 at $40.50 Form 4 ↗
May 6SIEGAL JONATHAN, Principal Accounting Officer$130,454
Form 4, May 8: sold 4,855 at $38.73 Form 4 ↗
Apr 2Hopper Jonathan Mark, Chief Medical Officer$121,520
Form 4, Apr 6: sold 3,472 at $35.00 Form 4 ↗
Mar 23Hagen Heidi, Director$486,163
Form 4, Mar 25: sold 15,000 at $32.41 Form 4 ↗
Mar 2Flynn Sean C., Chief Legal Officer$753,509
Form 4, Mar 4: sold 21,421 at $35.18 Form 4 ↗
Mar 2Halpin Michael, Chief Operating Officer$363,749
Form 4, Mar 4: sold 10,305 at $35.30 Form 4 ↗
Feb 11MCLAUGHLIN KEVIN F, Director$249,340
Form 4, Feb 13: sold 7,000 at $34.66 Form 4 ↗
Jan 7Halpin Michael, Chief Operating Officer$404,833
Form 4, Jan 9: sold 10,000 at $40.48 Form 4 ↗
Dec 3, 2025Wotton Paul K, Director$94,575
Dec 2, 2025Hopper Jonathan Mark, Chief Medical Officer$64,659
Form 4, Dec 4, 2025: sold 1,652 at $39.14 Form 4 ↗